1Twelves CJ,Cassidy J.Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer.BrJ Cancer,2002,86 (11):1670-1676.
2Twelves C.Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? Oncology (Huntingt),2002,16 (12):23-26.
2[1]Schullor J,Cassidy J,Dumont E,et al.Perferential activation of capecitabine in tumor following oral administration to colorectal cancer patients,Cancer chemother pharmatol,2000,45(4):291-297.
3[4]Cassidy J,Tabemero J.XELOX(capecitabine plus oxalipain):active first-line therapy for patients with metastatic colorectal cancer.J Clin Oncel.2004,22(11):2084-2091.
4[5]DeVita F,Orditur M,Matcno E,et al.A phase Ⅲ study of biweely oxaliplatine plus infusiona15-fluorouracil and folinic acid[FOLFOX-4] as first-line treatment of advanced gastric cancer patients.Br J Cancer,2005,92(9):16544-1649.
5[6]Scheithaner W,Kornek GV,Radere rM,et al.Randomized Multicenter phase Ⅱ trial of two different schedules of capeeitabine plus oxalipatin as first-line treatment in advanced colorectal cancer.J Clin Oncol,2003,21(7):1307-1312.
